METHODS: Current cryptococcosis and coccidioidomycosis surveillance strategies draw many parallels and include passive reporting of human and animal cases, and environmental sampling. GIS mapping and ecologic modeling are used to better understand geographic distribution and environmental niche. Whole genome or multilocus sequence typing (WGST or MLST) are used to genotype isolates, and, in combination with patient travel histories, identify locally acquired infections. C. gattii and C. immitis surveillance data from 2006-2015 were used to describe the epidemiology of both pathogens in Washington. Human cases meeting the CSTE confirmed case definition for either condition were included along with animal cases and soil positive locations.
RESULTS: Cases of C. gattii infection remain stable in Washington; 2-10 reports are received each year, with 46 cases reported since 2006. Animals are disease sentinels; cats are the most commonly reported animals infected, and disease appears to cluster in specific geographic locations in Western Washington. The epidemiology of coccidioidomycosis cases identified to-date differs from that reported from highly endemic areas; this is most likely due to underreporting of disease in Washington. Based on clinical presentation and hospitalization data only severe cases of coccidioidomycosis with Washington exposure are being diagnosed and reported. Targeted environmental sampling has confirmed the existence of both organisms in Washington.
CONCLUSIONS: Continued work is needed to increase awareness of fungal disease among healthcare providers and veterinarians to improve disease reporting and case finding, and to continue soil sampling and analysis to increase our understanding of the environmental niche and geographic ranges of the fungi. Collaborative planning, implementation, and evaluation will drive emerging fungal disease surveillance in the Pacific Northwest.